Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-04-19FDA Approved: METOCLOPRAMIDE — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA's original application for metoclopramide hydrochloride, a generic version of metoclopramide.
-
FDA approval · 2013-04-05FDA Approved: BASIC CARE LANSOPRAZOLE — Supplemental Application (Amazon.com Services LLC)
FDA approved a supplemental application for BASIC CARE LANSOPRAZOLE (lansoprazole) from Amazon.com Services LLC, a generic lansoprazole prod…
-
CLINICAL_TRIALS research · 2013-04-05Clinical Trial Update: Study of Erythromycin in GER-Associated Apnea of the Newborn [NA]
This entry describes a University of Virginia–sponsored clinical trial testing erythromycin for gastroesophageal reflux–associated apnea in …
-
CLINICAL_TRIALS research · 2013-04-04Clinical Trial Update: Decision Aid for Gastroesophageal Reflux Disease Management
This clinical trial update discusses a decision aid for managing gastroesophageal reflux disease and related conditions, including Barrett's…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) [Phase 4]
A Phase 4 randomized, double-blind, placebo-controlled trial is evaluating Wu-Chu-Yu Tang for gastroesophageal reflux disease; current statu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-01FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients [Phase 2]
Phase 2 clinical trial update from AstraZeneca reports symptom improvements in patients with gastroesophageal reflux disease; results posted…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn [Phase 4]
Phase 4 clinical trial evaluating the safety and efficacy of IQP-LH-101 for postprandial heartburn has been completed.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis
A completed clinical trial measured salivary epidermal growth factor (EGF) levels before and after treatment of reflux laryngitis in patient…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors [Phase 4]
Phase 4 trial evaluating how often eosinophilic esophagitis occurs in patients with heartburn refractory to proton pump inhibitors; the stud…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients
This completed clinical trial identifies factors that predict response to proton pump inhibitors in patients with gastroesophageal reflux di…
-
FDA approval · 2013-02-22FDA Approved: FAMOTIDINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for famotidine submitted by Alembic Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole [Phase 4]
Phase 4 trial evaluating esomeprazole 20 mg once daily in patients with gastroesophageal reflux disease who continued heartburn after rabepr…
-
FDA approval · 2013-02-11FDA Approved: NIZATIDINE — Supplemental Application (Epic Pharma, LLC)
FDA approved Epic Pharma, LLC's supplemental application to market a generic nizatidine product (an H2 receptor blocker) under an ANDA, expa…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis [Phase 3]
Phase 3 trial comparing a pantoprazole formulation to the currently marketed pantoprazole tablet in patients with gastroesophageal reflux di…
-
CLINICAL_TRIALS research · 2013-01-28Clinical Trial Update: Barrett's Esophagus Patient Registry
Barrett's esophagus patient registry update sponsored by Massachusetts General Hospital; the trial status is currently unknown. The conditio…
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: The Use of International GerdQ Questionnaire
A completed clinical trial sponsored by AstraZeneca evaluated the use of the International GerdQ questionnaire in relation to gastroesophage…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Does Omeprazole Decrease Intestinal Calcium Absorption? [Phase 4]
A Phase 4 clinical trial investigated whether omeprazole reduces intestinal calcium absorption in individuals with osteoporosis and related …
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus [Phase 1]
Phase 1 trial examining the role of acid reflux and stromal fibroblasts in Barrett's Esophagus has completed.
-
CLINICAL_TRIALS withdrawal · 2013-01-16Clinical Trial Update: Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability
A Duke University-sponsored clinical trial evaluating maternal-infant therapeutics for safety, mortality, and disability has been withdrawn;…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy [NA]
This completed clinical trial evaluated impedance-pH monitoring in GERD patients on and off proton pump inhibitor therapy, with results post…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. [Phase 2]
A Phase 2b dose-finding trial of AZD0865 with esomeprazole in gastroesophageal reflux disease with erosive esophagitis has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis. [Phase 2]
A completed Phase IIb dose-finding trial evaluated AZD0865 in combination with esomeprazole for gastroesophageal reflux disease without eros…
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: Detection of Minimal Change Esophagitis Using Confocal Laser Endomicroscopy
This clinical trial update notes the termination of a study evaluating detection of minimal change esophagitis in gastroesophageal reflux di…
-
FDA label_change · 2012-12-20FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (lansoprazole) filed by Takeda, extending its labeling with additional indications.